Maravai Lifesciences Holdings Inc (MRVI) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Maravai Lifesciences Holdings Inc   (NASDAQ: MRVI)


Maravai Lifesciences Holdings Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Maravai Lifesciences Holdings Inc's ROI in the second quarter of 2026?
Maravai Lifesciences Holdings Inc recorded a cumulative net loss of $-136 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -15.99%.

Within the Healthcare sector 12 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2832 to 3237.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -28.77 % -31.62 % -33.42 % -34.29 % -31.63 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 716 828 886 974 1,029
Return On Investment (TTM) -15.99 % -19.83 % -22.99 % -18.03 % -20.58 %
MRVI's Overall Ranking # 3237 # 2832 # 2604 # 3094 # 2589
Seq. Investment Change TTM -8.42 % -7.42 % -6.65 % -9.99 % -12.09 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -136 -184 -231 -194 -246

MRVI Company Profile >> Back to MRVI Roi Comparisons >> See Annual MRVI Return On Investment



Return On Investment MRVI's Ranking
Within: No.
Industry # 3
Sector # 13
Overall # 3237

Return On Investment Statistics
High Average Low
27.74 %
1.45 %
-28.13 %
(Mar 31 2022)   (Jun 30 2025)



  News about Maravai Lifesciences Holdings Inc Return on Investment ROI

Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer

June 25, 2025

Maravai LifeSciences Welcomes Rajesh Asarpota as CFO Amidst Challenging TimesIn a move to bolster its leadership team, Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI)—a global provider of life science reagents and services—has announced the appointment of Rajesh Raj Asarpota as the new Executive Vice President (EVP) and Chief Financial Officer (CFO), effective June 30, 2025. Asarpota succeeds Kevin Herde, who will transition to an advisory role on the same date, allowing him to facilitate a smooth transition of responsibilities.The announcement comes at a pivotal time for Maravai, which has faced increasing scrutiny from investors and legal challenges in recent months. Notably, Susannah Gray, Chair of the Audit Committee at Maravai s Board of Directors, expressed gratitude towards Herde for his significant contributions over the past eight years, stating, “He has played an important role in shaping the company’s foundation, and we’re grateful for his continued support in an advisory role during this transition.





Financial Statements
Maravai Lifesciences Holdings Inc's II. Quarter Investments $ 716 Millions MRVI's Balance sheet
Maravai Lifesciences Holdings Inc's II. Quarter Income $ -22 Millions Quarterly MRVI's Income Statement
MRVI's Income by Division See MRVI's Income by Division


MRVI Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 856 1,172 1,687 2,532 2,054
Y / Y Investment Growth -26.98 % -30.53 % -33.37 % 23.26 % -
Net Income in Millions -231 -260 -138 491 469
Y / Y Net Income Growth - - - 4.56 % -
Annual Return On Investment -26.96 % -22.15 % -8.2 % 19.38 % 22.84 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MRVI's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MRVI's Competitors
Subscribers only: Roi for Maravai Lifesciences Holdings Inc's Suppliers
Subscribers only: Return On Investment for MRVI's Customers

Other Ratios
MRVI's Roa MRVI's Inventory Turnover Ratio MRVI's Growth Rates MRVI's Dividend Statistics
MRVI's Profitability Ratios MRVI's Asset Turnover Ratio MRVI's Dividend Growth
MRVI's Roe MRVI's Valuation Ratios MRVI's Financial Strength Ratios MRVI's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-12T06:24:55+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.